Fertility and sterility · 2008
Contraception in hereditary angioedema.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sanhueza Pablo I
Аннотация
OBJECTIVE: To report a case of successful use of a transdermal contraceptive in a patient with hereditary angioedema.
DESIGN: Case report.
SETTING: University medical center.
PATIENT(S): A patient who had used oral contraceptives contracted SC and submucosal tumefaction every 1 or 2 months. She was diagnosed with type I hereditary angioedema. It was determined that she was complement C4 deficient and C1-inhibitor quantitative deficient but functional C1-inhibitor normal. After she was diagnosed, the use of oral contraceptives was contraindicated.
INTERVENTION(S): Oral contraceptives were suspended, and a hormonal transdermal contraceptive was started.
MAIN OUTCOME MEASURE(S): The absence of symptoms after 26 months using a transdermal contraceptive.
RESULT(S): After 26 months of using this treatment, the patient has not experienced any symptoms of the hereditary angioedema.
CONCLUSION(S): The use of hormonal contraceptives transdermally can be an alternative in patients with hereditary angioedema.
DESIGN: Case report.
SETTING: University medical center.
PATIENT(S): A patient who had used oral contraceptives contracted SC and submucosal tumefaction every 1 or 2 months. She was diagnosed with type I hereditary angioedema. It was determined that she was complement C4 deficient and C1-inhibitor quantitative deficient but functional C1-inhibitor normal. After she was diagnosed, the use of oral contraceptives was contraindicated.
INTERVENTION(S): Oral contraceptives were suspended, and a hormonal transdermal contraceptive was started.
MAIN OUTCOME MEASURE(S): The absence of symptoms after 26 months using a transdermal contraceptive.
RESULT(S): After 26 months of using this treatment, the patient has not experienced any symptoms of the hereditary angioedema.
CONCLUSION(S): The use of hormonal contraceptives transdermally can be an alternative in patients with hereditary angioedema.